Tibolone: what does tissue specific activity mean?

S Palacios1

  • 1Institute Palacios of Woman's Health, c/ Jorge Juan 36, 28001, Madrid, Spain. instituto.palacios@retemail.es

Maturitas
|February 15, 2001
PubMed

Insights

Tibolone exhibits tissue-specific estrogenic, progestational, and androgenic activities. Its unique profile effectively treats menopausal symptoms without stimulating sensitive tissues, due to complex metabolic and receptor interactions.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Reproductive Medicine

Background:

  • Tibolone, a synthetic steroid, possesses weak estrogenic, progestational, and androgenic activities.
  • Its therapeutic effects are known to be tissue-dependent.
  • Understanding these mechanisms is crucial for hormone replacement therapy.

Purpose of the Study:

  • To elucidate the mechanisms behind tibolone's tissue-specific activity.
  • To explain how tibolone effectively treats menopausal symptoms while sparing breast and endometrial tissues.
  • To correlate molecular interactions with clinical outcomes.

Main Methods:

  • Review of preclinical and clinical data on tibolone's pharmacological profile.
  • Analysis of tibolone's metabolic pathways and its interaction with steroid receptors.
  • Investigation of local tissue metabolism and its influence on biological activity.

Main Results:

  • Tibolone demonstrates variable hormonal effects based on the target tissue.
  • Clinical evidence shows efficacy in managing climacteric symptoms and preventing menopausal sequelae.
  • No adverse stimulation of breast and endometrial tissues was observed.

Conclusions:

  • Tibolone's tissue-specific action is attributed to its unique metabolism and interaction with steroid receptors.
  • Metabolic conversion to various active compounds and local tissue metabolism play key roles.
  • The balance of these mechanisms dictates the overall clinical response in specific tissues.

Related Concept Videos

Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...